What’s more, an investigation into the underlying mechanisms established GML as a potential immunosuppressant for therapeutic applications, including autoimmune, psoriasis and inflammatory bowel disease, based on the effective anti-inflammatory activity and the T cell-suppressed functions of GML [6]. The gene discussed is GML; the disease is psoriasis.